Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on ...

The FDA has approved datopotamab deruxtecan (Dato-DXd, Datroway, Daiichi Sankyo) for the treatment of patients with ...

Dr Sunnie Kim previews key GI trials highlighting novel bispecific antibodies, dual immunotherapy combinations, KIT ...

Insomnia, sleepiness, fatigue, and stress were associated with higher depression scores, but caffeine appeared to lessen the ...

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than ...

Insights from ASCO 2026, including anticipated presentations, key takeaways, and how emerging research in GI cancers may affect patient care.

A cohort study of births in Brazil found increased hospitalization risk through age 3 after maternal chikungunya; results ...

The conditional authorization covers adults and children aged 2 years and older with severe or life-threatening ...

Novel CRISPR-Cas9 treatments are proving effective in reversing disease for life. But ensuring their long-term safety will ...

Researchers have identified a compound produced by a variety of land snail that prevents blood clots without prolonging ...

An early evaluation of 'Swap to Stop' scheme in England shows a 4-week quit rate of 34.3% among recipients of free ...

Emerging evidence suggests that leptin, dysbiosis, and altered innate immunity may contribute to poor asthma control in ...